(Q31935738)

5 July 2017

1 reference

title

Advances in DNA gyrase inhibitors (English)

1 reference

5 July 2017

Kim OK

1

1 reference

5 July 2017

Ohemeng K

series ordinal

2

1 reference

5 July 2017

Barrett JF

series ordinal

3

1 reference

5 July 2017

language of work or name

English

0 references

publication date

1 February 2001

1 reference

Expert Opinion on Investigational Drugs

5 July 2017

1 reference

5 July 2017

10

1 reference

5 July 2017

2

1 reference

5 July 2017

199-212

1 reference

The twisted 'life' of DNA in the cell: bacterial topoisomerases

5 July 2017

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.199

The interaction between coumarin drugs and DNA gyrase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.199

Biological characterization of cyclothialidine, a new DNA gyrase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.199

Cyclothialidine and its congeners: a new class of DNA gyrase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.199

Toxic effects of quinolone antibacterial agents on the musculoskeletal system in juvenile rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.199

Structure-activity and structure-side-effect relationships for the quinolone antibacterials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.199

Gatifloxacin: a new fluoroquinolone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.199

Moxifloxacin (Bay 12-8039): a new methoxy quinolone antibacterial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.199

Antimicrobial activity of advanced-spectrum fluoroquinolones tested against more than 2000 contemporary bacterial isolates of species causing community-acquired respiratory tract infections in the United States (1999).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.199

In vitro antimicrobial activity of gatifloxacin against 873 clinical isolates from respiratory tract, urinary tract and surgical infections during 1997-1998 in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.199

In vitro antibacterial spectrum of a new broad-spectrum 8-methoxy fluoroquinolone, gatifloxacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.199

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.199

Prevalence of gyrA, gyrB, parC, and parE mutations in clinical isolates of Streptococcus pneumoniae with decreased susceptibilities to different fluoroquinolones and originating from Worldwide Surveillance Studies during the 1997-1998 respiratory se

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.199

The 2-pyridone antibacterial agents: bacterial topoisomerase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.2.199

Cyclothialidine analogs, novel DNA gyrase inhibitors

21 January 2018

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.50.402

Identifiers

DOI

10.1517/13543784.10.2.199

1 reference

5 July 2017

1 reference